Chair(s): Katerina Antoniou, Ioannis Vogiatzis
Session type: Pro-Con debate
Nazia Chaudhuri
Session content
Pro: I would start antifibrotic therapy in an 80-year-old with comorbidities
Nazia Chaudhuri
Replay
Slides
George Margaritopoulos
Replay
Slides
Replay
Session aims
To highlight some of the emerging themes and controversies regarding the early treatment of interstitial lung diseases; to discuss the common clinical dilemmas and misconceptions that occur in clinical practise regarding the influence of age and comorbidities on the decision to start anti-inflammatory or antifibrotic treatment; to explore the role of risk stratification and early treatment in connective tissue diseases.